Serologic Evidence for Cryptococcus neoformans Infection in Early Childhood
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Objective.: Cryptococcus neoformans is an important cause of central nervous system infection in adults with acquired immunodeficiency syndrome (AIDS) but an unusual cause of disease in children with AIDS. The basis for this age-related difference in incidence is not known but may be caused by differences in exposure or immune response. The objective of this study was to determine whether the low prevalence of cryptococcal disease among children is related to a lack of exposure to C neoformans. Methods.: Sera were obtained from 185 immunocompetent individuals ranging in age from 1 week to 21 years who were being evaluated in an urban emergency department. Sera were analyzed for antibodies to C neoformans and Candida albicans proteins by immunoblotting. Immunoblot patterns were compared with those obtained from sera of patients with cryptococcosis (n = 10) and workers in a laboratory devoted to the study of C neoformans. The specificity of our results was confirmed by several approaches, including antibody absorption and blocking studies. Sera were also analyzed for the presence of cryptococcal polysaccharide by both enzyme-linked immunosorbent assay and latex agglutination assays. Results.: Sera from children 1.1 to 2 years old demonstrated minimal reactivity to C neoformansproteins. In contrast, the majority of sera from children >2 years old recognized many (≥6) C neoformans proteins. For children between 2.1 and 5 years old, 56% of sera (n = 25) reacted with many proteins, whereas for children >5 years old (n = 120), 70% of samples reacted with many proteins. Reactivity was decreased by absorbing sera with C neoformans extracts or by preincubating blots with sera from experimentally infected but not from control rats. Reactivity to C neoformans proteins did not correlate with reactivity to C albicans proteins, which was common in sera from children between the ages of 1.1 and 2 years. Cryptococcal polysaccharide was detected at a titer of 1:16 (∼10 ng/mL) in the sera of 1 child, a 5.6-year-old boy who presented to the emergency department with vomiting. Conclusions.: Our findings provide both indirect and direct evidence of C neoformans infection in immunocompetent children. Our results indicate that C neoformans infects a majority of children living in the Bronx after 2 years old. These results are consistent with several observations: the ubiquitous nature of C neoformans in the environment, including its association with pigeon excreta; the large number of pigeons in urban areas; and the increased likelihood of environmental exposure for children once they have learned to walk. The signs and symptoms associated with C neoformans infection in immunocompetent children remained to be determined. Primary pulmonary cryptococcosis may be asymptomatic or produce symptoms confused with viral infections and, therefore, not recognized as a fungal infection. Our results suggest that the low incidence of symptomatic cryptococcal disease in children with AIDS is not a result of lack of exposure toC neoformans. These findings have important implications for C neoformans pathogenesis and the development of vaccine strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1327 · Cited by 995
Epidemiological Evidence for Dormant Cryptococcus neoformans Infection
Garcia-Hermoso, D., Janbon, G., & Dromer, F. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.10.3204-3209.1999 · Cited by 323
Hajjeh, R. A., Conn, L. A., Stephens, D. S., Baughman, W., Hamill, R., Graviss, E., Pappas, P. G., Thomas, C., Reingold, A., Rothrock, G., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314606 · Cited by 275
Currie, B. P., & Casadevall, A. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.6.1029 · Cited by 242
Self-citationDevi, S. J., Schneerson, R., Egan, W., Ulrich, T. J., Bryla, D., Robbins, J. B., & Bennett, J. E. (1991) · Infection and Immunity · doi:10.1128/iai.59.10.3700-3707.1991 · Cited by 184
Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat
Goldman, D., Lee, S. C., & Casadevall, A. (1994) · Infection and Immunity · doi:10.1128/iai.62.11.4755-4761.1994 · Cited by 183
Self-citationMonoclonal antibody based ELISAs for cryptococcal polysaccharide
Casadevall, A., Mukherjee, J., & Scharff, M. D. (1992) · Journal of Immunological Methods · doi:10.1016/0022-1759(92)90209-c · Cited by 166
Self-citationMcManus, E. J., & Jones, J. M. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.21.5.681-685.1985 · Cited by 164
Goldman, D. L., Lee, S. C., Mednick, A. J., Montella, L., & Casadevall, A. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.832-838.2000 · Cited by 156
Self-citationNosanchuk, J. D., Shoham, S., Fries, B. C., Shapiro, D. S., Levitz, S. M., & Casadevall, A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-3-200002010-00006 · Cited by 155
Self-citation
Cited by
Laccase Properties, Physiological Functions, and Evolution
Janusz, G., Pawlik, A., Świderska-Burek, U., Polak, J., Sulej, J., Jarosz-Wilkołazka, A., & Paszczyński, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030966 · Cited by 715
Maziarz, E. K., & Perfect, J. R. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.006 · Cited by 698
The contribution of melanin to microbial pathogenesis: Melanin and microbial pathogenesis
Nosanchuk, J. D., & Casadevall, A. (2003) · Cellular Microbiology · doi:10.1046/j.1462-5814.2003.00268.x · Cited by 650
Self-citationAntifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Roemer, T., & Krysan, D. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019703 · Cited by 593
Cryptococcus: from environmental saprophyte to global pathogen
May, R. C., Stone, N. R. H., Wiesner, D. L., Bicanic, T., & Nielsen, K. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.6 · Cited by 541
Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis
Kwon-Chung, K. J., Fraser, J. A., Doering, T. L., Wang, Z. A., Janbon, G., Idnurm, A., & Bahn, Y.-S. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019760 · Cited by 531
(2014) · doi:10.1128/cmr.00126-13 · Cited by 437
Husain, S., Wagener, M. M., & Singh, N. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0703.010302 · Cited by 405
The Biology of the Cryptococcus neoformans Species Complex
Lin, X., & Heitman, J. (2006) · Annual Review of Microbiology · doi:10.1146/annurev.micro.60.080805.142102 · Cited by 397
Chayakulkeeree, M., & Perfect, J. R. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.07.001 · Cited by 378
The Cryptococcus neoformans Capsule: a Sword and a Shield
O'Meara, T. R., & Alspaugh, J. A. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-12 · Cited by 364
Perfect, J. R., & Casadevall, A. (2002) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(02)00036-3 · Cited by 363
Self-citationBicanic, T., & Harrison, T. S. (2004) · British Medical Bulletin · doi:10.1093/bmb/ldh043 · Cited by 361
Spores as Infectious Propagules of Cryptococcus neoformans
Velagapudi, R., Hsueh, Y.-P., Geunes-Boyer, S., Wright, J. R., & Heitman, J. (2009) · Infection and Immunity · doi:10.1128/iai.00542-09 · Cited by 327
Immune defence to invasive fungal infections: A comprehensive review
Pathakumari, B., Liang, G., & Liu, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110550 · Cited by 264
Singh, N., Alexander, B. D., Lortholary, O., Dromer, F., Gupta, K. L., John, G. T., del Busto, R., Klintmalm, G. B., Somani, J., Lyon, G. M., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/511438 · Cited by 264
Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999–2007
Galanis, E., MacDougall, L., Kidd, S., Morshed, M., & the British Columbia Cryptococcus gattii Working Group (2010) · Emerging Infectious Diseases · doi:10.3201/eid1602.090900 · Cited by 263
HIV-associated cryptococcal meningitis
Jarvis, J. N., & Harrison, T. S. (2007) · AIDS · doi:10.1097/qad.0b013e3282a4a64d · Cited by 252
Cryptococcal Interactions with the Host Immune System
Voelz, K., & May, R. C. (2010) · Eukaryotic Cell · doi:10.1128/ec.00039-10 · Cited by 202
Vesicle-associated melanization in Cryptococcus neoformans
Eisenman, H. C., Frases, S., Nicola, A. M., Rodrigues, M. L., & Casadevall, A. (2009) · Microbiology · doi:10.1099/mic.0.032854-0 · Cited by 144
Self-citationShea, J. M., Kechichian, T. B., Luberto, C., & Del Poeta, M. (2006) · Infection and Immunity · doi:10.1128/iai.00768-06 · Cited by 110
“Exposure to the microorganism is common (19), but the majority of subjects do not develop clinical disease.”
BackgroundCryptococci at the brain gate: break and enter or use a Trojan horse?
Casadevall, A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42949 · Cited by 89
Self-citationStie, J., Bruni, G., & Fox, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005780 · Cited by 85
“Although the immunosuppressed are at greatest risk of infection and death, healthy individuals can also contract the disease due to the widespread presence of the fungus in the environment [17].”
BackgroundA titanic drug resistance threat in Cryptococcus neoformans
Zafar, H., Altamirano, S., Ballou, E. R., & Nielsen, K. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.11.001 · Cited by 76
“Serological studies show this initial pulmonary infection is acquired early in life, typically by 5 years of age [22, 23].”
BackgroundMechanisms of Pulmonary Escape and Dissemination by Cryptococcus neoformans
Denham, S., & Brown, J. (2018) · Journal of Fungi · doi:10.3390/jof4010025 · Cited by 67
“neoformans is predicted to be near universal, first occurring in early childhood [14].”
BackgroundSynergistic and antagonistic drug interactions in the treatment of systemic fungal infections
Wambaugh, M. A., Denham, S. T., Ayala, M., Brammer, B., Stonhill, M. A., & Brown, J. C. (2020) · eLife · doi:10.7554/elife.54160 · Cited by 65
Davis, J. M., Huang, M., Botts, M. R., Hull, C. M., & Huttenlocher, A. (2016) · Infection and Immunity · doi:10.1128/iai.00506-16 · Cited by 62
Sabiiti, W., & May, R. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035455 · Cited by 31
Complex Roles of Annexin A2 in Host Blood–Brain Barrier Invasion by Cryptococcus neoformans
Fang, W., Fa, Z., Xie, Q., Wang, G., Yi, J., Zhang, C., Meng, G., Gu, J., & Liao, W. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12673 · Cited by 24
Dancing cheek to cheek: Cryptococcus neoformans and phagocytes
Zhang, M., Sun, D., & Shi, M. (2015) · SpringerPlus · doi:10.1186/s40064-015-1192-3 · Cited by 19
Metadata
- Authors
- Goldman, D. L., Khine, H., Abadi, J., Lindenberg, D. J., Pirofski, L.-A., Niang, R., & Casadevall, A.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2001-05-01
- Volume
- 107
- Issue
- 5
- Pages
- e66-e66
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2068790641
- Cited by
- 413
- References
- 23
- FWCI
- 7.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.